Disclosures for "Susceptibility-based Imaging Aids Accurate Distinction of Pediatric-onset MS from Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease"
-
Dr. Virupakshaiah has nothing to disclose.
-
Dr. Sacco has nothing to disclose.
-
The institution of Nico Papinutto has received research support from National Center for Advancing Translational Sciences, National Institutes of Health, through a UCSF-CTSI Grant . The institution of Nico Papinutto has received research support from Race to Erase MS Foundation.
-
Dr. Schoeps has nothing to disclose.
-
Mr. Science has nothing to disclose.
-
Ms. ZHAO has nothing to disclose.
-
Jennifer Arjona has nothing to disclose.
-
William Stern has nothing to disclose.
-
Ms. Chong has nothing to disclose.
-
Janace Hart has nothing to disclose.
-
Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with Genzyme. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with Genentech. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with Alexion.
-
The institution of Dr. Sati has received research support from National Multiple Sclerosis Society. The institution of Dr. Sati has received research support from National Institutes of Health. Dr. Sati has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Henry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MEDDAY. Dr. Henry has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Henry has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Henry has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi/Genzyme.
-
Dr. Waubant has received personal compensation in the range of $500-$4,999 for serving as a Consultant for emerald pharmaceuticals. Dr. Waubant has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for elsevier. The institution of Dr. Waubant has received research support from NIH. The institution of Dr. Waubant has received research support from NMSS. The institution of Dr. Waubant has received research support from PCORI. The institution of Dr. Waubant has received research support from Race to Erase MS. The institution of Dr. Waubant has received research support from Roche. The institution of Dr. Waubant has received research support from Biogen. The institution of Dr. Waubant has received research support from Department of Defense. Dr. Waubant has received publishing royalties from a publication relating to health care.